Join the club for FREE to access the whole archive and other member benefits.

Sumitomo Pharma

R & D company based in Japan

Our Mission is "To contribute broadly to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide."

By channeling efforts into the research and development of new drugs, Sumitomo Pharma aims to realize this Mission and provide innovative and useful pharmaceuticals and healthcare solutions to people in Japan and around the world.

We are committed to contributing to the betterment of healthcare and fuller lives of people in three disease areas - Oncology, Psychiatry & Neurology (CNS), and Other areas (urological diseases, gynecological diseases, rare diseases, infectious diseases, etc.) - as well as in such modalities as small molecules and regenerative medicine/cell therapy.

Previously known as Sumitomo Dainippon Pharma Co., Ltd.

Visit website: https://www.sumitomo-pharma.com/

 sumitomo.pharma

 sumitomo-pharma

 UCv0WMXKY1bUQfLIuxIETODg

Details last updated 03-Apr-2026

Sumitomo Pharma News

Clinical trials now up for Exscientia's world first AI-made drug

Clinical trials now up for Exscientia's world first AI-made drug

pharmaphorum - 30-Jan-2020

Partnering with Japan's DSP, a milestone is reached in OCD treatment

Drug molecule developed using AI to undergo human trials

Drug molecule developed using AI to undergo human trials

BBC - 30-Jan-2020

Can speed up drug discovery process using artificial intelligence

World’s First Commercial iPSC Cell Plant Opens

World’s First Commercial iPSC Cell Plant Opens

The Scientist - 23-Mar-2018

Will produce cells derived from iPS cells for commercial applications. Existing iPSC production ...